Ross Margulies to Speak at the Nephron Inaugural 2026 D.C. Summit

Manatt Health Partner will speak on a panel titled, “Drug Prices: From IRA to MFN to 340B,” at the Nephron D.C. Summit, hosted by Nephron Healthcare Investment Research, on April 15 in Washington, D.C.

The session will explore key policy and regulatory developments shaping drug pricing, including the implications of the Inflation Reduction Act (IRA), Most Favored Nation (MFN) models and the 340B Drug Pricing Program. Panelists will discuss how these frameworks are impacting manufacturers, providers and payers, as well as considerations for navigating an evolving pricing and reimbursement landscape.

Learn more and register .